Dann L. Parker
Merck & Co., Inc., Rahway, NJ, USA (United States)
ORCID: 0000-0002-2338-4540Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 5 papers. Top paper: “Cyp1 Inhibition Prevents Doxorubicin‐Induced Cardiomyopathy in a Zebrafish Heart‐Failure Model”.
Peter S. Kutchukian, Rajan Anand, Jason E. Imbriglio, Christine L. Andrews, Hugo Padilla +12 more
Steve D. Knutson, James V. Oakley, Noah B. Bissonnette, Daniel G. Oblinsky, Michael P. Schwoerer +8 more
James V. Oakley, Ciaran P. Seath, Jacob B. Geri, Aaron Trowbridge, Dann L. Parker +9 more
Stavros K. Kariofillis, Andrew C. Johns, Jinwoo Kim, Dann L. Parker, Carlo P. Ramil +4 more
Stavros K. Kariofillis, Andrew C. Johns, Jin-Woo Kim, Jizhi Ni, Sang‐Ho Park +6 more